A team agent approach to postmarketing surveillance of adverse drug reactions

Yanqing Ji, Hao Ying, Daniel C. Barth-Jones, John Yen, Shizhuo Zhu, Richard E. Miller, R. Michael Massanari

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Citation (Scopus)

Abstract

Current postmarketing surveillance methods largely rely on spontaneous reports which suffer from serious underreporting, latency, and inconsistent reporting. Thus they are not ideal for rapidly identifying rare adverse drug reactions (ADRs). We propose an active, multi-agent computer software system, where each agent is empowered with teamwork capabilities such as anticipating information needs, identifying relevant ADR information, and continuously monitoring and proactively sharing such information in a collaborative fashion with other agents. The main purpose of this system is to help regulatory authorities (e.g., FDA in the U.S.) find previously unrecognized ADRs as early as possible. Another objective is to promote increased filing of on-line ADR reports thereby, addressing the severe underreporting problem with the current system. The proposed system has the potential to significantly accelerate the process of ADR discovery and response by utilizing electronic patient data distributed across many different sources and locations more effectively. Our preliminary system design is presented and some issues related to it are discussed.

Original languageEnglish (US)
Title of host publicationProceedings of the 2005 27th Annual International Conference of the Engineering in Medicine and Biology Society, IEEE-EMBS 2005
Pages6969-6972
Number of pages4
StatePublished - Dec 1 2005
Event2005 27th Annual International Conference of the Engineering in Medicine and Biology Society, IEEE-EMBS 2005 - Shanghai, China
Duration: Sep 1 2005Sep 4 2005

Publication series

NameAnnual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings
Volume7 VOLS
ISSN (Print)0589-1019

Other

Other2005 27th Annual International Conference of the Engineering in Medicine and Biology Society, IEEE-EMBS 2005
CountryChina
CityShanghai
Period9/1/059/4/05

Fingerprint

Pharmaceutical Preparations
Systems analysis
Monitoring

All Science Journal Classification (ASJC) codes

  • Signal Processing
  • Biomedical Engineering
  • Computer Vision and Pattern Recognition
  • Health Informatics

Cite this

Ji, Y., Ying, H., Barth-Jones, D. C., Yen, J., Zhu, S., Miller, R. E., & Massanari, R. M. (2005). A team agent approach to postmarketing surveillance of adverse drug reactions. In Proceedings of the 2005 27th Annual International Conference of the Engineering in Medicine and Biology Society, IEEE-EMBS 2005 (pp. 6969-6972). [1616109] (Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings; Vol. 7 VOLS).
Ji, Yanqing ; Ying, Hao ; Barth-Jones, Daniel C. ; Yen, John ; Zhu, Shizhuo ; Miller, Richard E. ; Massanari, R. Michael. / A team agent approach to postmarketing surveillance of adverse drug reactions. Proceedings of the 2005 27th Annual International Conference of the Engineering in Medicine and Biology Society, IEEE-EMBS 2005. 2005. pp. 6969-6972 (Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings).
@inproceedings{a651067880ae4649b5e25b4269246228,
title = "A team agent approach to postmarketing surveillance of adverse drug reactions",
abstract = "Current postmarketing surveillance methods largely rely on spontaneous reports which suffer from serious underreporting, latency, and inconsistent reporting. Thus they are not ideal for rapidly identifying rare adverse drug reactions (ADRs). We propose an active, multi-agent computer software system, where each agent is empowered with teamwork capabilities such as anticipating information needs, identifying relevant ADR information, and continuously monitoring and proactively sharing such information in a collaborative fashion with other agents. The main purpose of this system is to help regulatory authorities (e.g., FDA in the U.S.) find previously unrecognized ADRs as early as possible. Another objective is to promote increased filing of on-line ADR reports thereby, addressing the severe underreporting problem with the current system. The proposed system has the potential to significantly accelerate the process of ADR discovery and response by utilizing electronic patient data distributed across many different sources and locations more effectively. Our preliminary system design is presented and some issues related to it are discussed.",
author = "Yanqing Ji and Hao Ying and Barth-Jones, {Daniel C.} and John Yen and Shizhuo Zhu and Miller, {Richard E.} and Massanari, {R. Michael}",
year = "2005",
month = "12",
day = "1",
language = "English (US)",
isbn = "0780387406",
series = "Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings",
pages = "6969--6972",
booktitle = "Proceedings of the 2005 27th Annual International Conference of the Engineering in Medicine and Biology Society, IEEE-EMBS 2005",

}

Ji, Y, Ying, H, Barth-Jones, DC, Yen, J, Zhu, S, Miller, RE & Massanari, RM 2005, A team agent approach to postmarketing surveillance of adverse drug reactions. in Proceedings of the 2005 27th Annual International Conference of the Engineering in Medicine and Biology Society, IEEE-EMBS 2005., 1616109, Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings, vol. 7 VOLS, pp. 6969-6972, 2005 27th Annual International Conference of the Engineering in Medicine and Biology Society, IEEE-EMBS 2005, Shanghai, China, 9/1/05.

A team agent approach to postmarketing surveillance of adverse drug reactions. / Ji, Yanqing; Ying, Hao; Barth-Jones, Daniel C.; Yen, John; Zhu, Shizhuo; Miller, Richard E.; Massanari, R. Michael.

Proceedings of the 2005 27th Annual International Conference of the Engineering in Medicine and Biology Society, IEEE-EMBS 2005. 2005. p. 6969-6972 1616109 (Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings; Vol. 7 VOLS).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

TY - GEN

T1 - A team agent approach to postmarketing surveillance of adverse drug reactions

AU - Ji, Yanqing

AU - Ying, Hao

AU - Barth-Jones, Daniel C.

AU - Yen, John

AU - Zhu, Shizhuo

AU - Miller, Richard E.

AU - Massanari, R. Michael

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Current postmarketing surveillance methods largely rely on spontaneous reports which suffer from serious underreporting, latency, and inconsistent reporting. Thus they are not ideal for rapidly identifying rare adverse drug reactions (ADRs). We propose an active, multi-agent computer software system, where each agent is empowered with teamwork capabilities such as anticipating information needs, identifying relevant ADR information, and continuously monitoring and proactively sharing such information in a collaborative fashion with other agents. The main purpose of this system is to help regulatory authorities (e.g., FDA in the U.S.) find previously unrecognized ADRs as early as possible. Another objective is to promote increased filing of on-line ADR reports thereby, addressing the severe underreporting problem with the current system. The proposed system has the potential to significantly accelerate the process of ADR discovery and response by utilizing electronic patient data distributed across many different sources and locations more effectively. Our preliminary system design is presented and some issues related to it are discussed.

AB - Current postmarketing surveillance methods largely rely on spontaneous reports which suffer from serious underreporting, latency, and inconsistent reporting. Thus they are not ideal for rapidly identifying rare adverse drug reactions (ADRs). We propose an active, multi-agent computer software system, where each agent is empowered with teamwork capabilities such as anticipating information needs, identifying relevant ADR information, and continuously monitoring and proactively sharing such information in a collaborative fashion with other agents. The main purpose of this system is to help regulatory authorities (e.g., FDA in the U.S.) find previously unrecognized ADRs as early as possible. Another objective is to promote increased filing of on-line ADR reports thereby, addressing the severe underreporting problem with the current system. The proposed system has the potential to significantly accelerate the process of ADR discovery and response by utilizing electronic patient data distributed across many different sources and locations more effectively. Our preliminary system design is presented and some issues related to it are discussed.

UR - http://www.scopus.com/inward/record.url?scp=33846915774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846915774&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:33846915774

SN - 0780387406

SN - 9780780387409

T3 - Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings

SP - 6969

EP - 6972

BT - Proceedings of the 2005 27th Annual International Conference of the Engineering in Medicine and Biology Society, IEEE-EMBS 2005

ER -

Ji Y, Ying H, Barth-Jones DC, Yen J, Zhu S, Miller RE et al. A team agent approach to postmarketing surveillance of adverse drug reactions. In Proceedings of the 2005 27th Annual International Conference of the Engineering in Medicine and Biology Society, IEEE-EMBS 2005. 2005. p. 6969-6972. 1616109. (Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings).